Iclaprim

The FDA is forcing a small antibiotic player back to the clinic for a new trial — 10 years after first rejection
Endpoints
Thu, 06/6/19 - 09:52 am
Motif Bio
FDA
antibiotics
Iclaprim
Liver toxicity concerns spike Motif Bio’s iclaprim filing
Fierce Biotech
Thu, 02/14/19 - 05:55 pm
FDA
Motif Biosciences
ABSSSI
Iclaprim
complete response letter
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Yahoo/Benzinga
Sun, 02/10/19 - 11:08 pm
Motif Biosciences
Iclaprim
Merck
Keytruda
melanoma
JNJ
esketamine
ASCO
Pfizer
Veru. earnings
Aveo Pharmaceuticals
Calithera Biosciences
Mark Your Calendar For These February PDUFA Dates
Yahoo/Benzinga
Sat, 02/2/19 - 12:31 pm
FDA
DWP-450
Evolus
MOTIF BIO PLC/S ADR
Iclaprim
Bausch Health
Duobrii
Merck
Keytruda
Incyte
Novartis
ruxolitinib
Novo Nordisk
N8-GP
Motif delivers more strong data on its antibiotic
Biopharma Dive
Thu, 10/5/17 - 06:07 pm
Motif Biosciences
antibiotics
Iclaprim
skin infections